Review: could Rituxan cause Capillary Leak Syndrome?


Capillary leak syndrome is reported only by a few people who take Rituxan. We study 18,659 people who have side effects while taking Rituxan from FDA and social media. Among them, 5 have Capillary leak syndrome. Find out below who they are, when they have Capillary leak syndrome and more.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Rituxan has active ingredients of rituximab. It is often used in rheumatoid arthritis. (latest outcomes from Rituxan 18,902 users)

Capillary Leak Syndrome

Capillary leak syndrome (capillary leaks plasma) has been reported by people with acute myeloid leukaemia, breast cancer, acute lymphocytic leukemia (all), pain, preventive health care (latest reports from 1,208 Capillary leak syndrome patients).

On Oct, 21, 2016

18,659 people reported to have side effects when taking Rituxan.
Among them, 5 people (0.03%) have Capillary Leak Syndrome

Number of reports submitted per year:

Could Rituxan cause Capillary leak syndrome?

Time on Rituxan when people have Capillary Leak Syndrome *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Capillary Leak Syndrome when taking Rituxan *:

  • female: 80 %
  • male: 20 %

Age of people who have Capillary Leak Syndrome when taking Rituxan *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Top conditions involved for these people *:

  • Lymphoma (3 people, 60.00%)
  • Thrombocytopenia (2 people, 40.00%)

Top co-used drugs for these people *:

  • Vioxx (2 people, 40.00%)
  • Triamterene (2 people, 40.00%)
  • Fludarabine Phosphate (2 people, 40.00%)
  • Dyazide (2 people, 40.00%)
  • Atenolol (2 people, 40.00%)

Top other side effects for these people *:

  • Pleural Effusion (4 people, 80.00%)
  • Respiratory Failure (3 people, 60.00%)
  • Asthenia (3 people, 60.00%)
  • Dizziness (2 people, 40.00%)
  • Disseminated Intravascular Coagulation (2 people, 40.00%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Capillary leak syndrome when taking Rituxan?

Browse all side effects of Rituxan

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Capillary leak syndrome

Capillary leak syndrome

Could your condition cause Capillary leak syndrome

Capillary leak syndrome

Related studies

Recent conversations of related support groups:

Can you answer these questions?

More questions for: Rituxan, Capillary leak syndrome

You may be interested in these reviews

More reviews for: Rituxan, Capillary leak syndrome

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.